Geron Plans to Announce First Quarter 2026 Financial Results on May 6, 2026

Rhea-AI Summary

Geron (Nasdaq: GERN) will release its first quarter 2026 financial results and business highlights before the market opens on May 6, 2026.

The company will host a conference call and webcast at 8:00 a.m. Eastern Time, with live and archived audio available from the Investors and Media section of its website at www.geron.com.

News Market Reaction – GERN

+3.33%

+3.33% Session close to close

In the Apr 22 session, GERN gained 3.33%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement sets the schedule for first quarter 2026 results and an 8:00 a.m. ET conference ca...

Analysis

This announcement sets the schedule for first quarter 2026 results and an 8:00 a.m. ET conference call on May 6, 2026, without disclosing new financial metrics. Historically, a similar earnings date notice led to a mild -0.62% move, suggesting timing updates alone have been low-impact. Investors may focus on how upcoming results relate to prior RYTELO revenues, cash of $421.5M, and ongoing commercialization and restructuring efforts.

Key Figures

Total revenue: $47.3M Net product revenue: $47.2M Net loss: $18.4M +5 more

8 metrics

Total revenue $47.3M Q3 2025 results

Net product revenue $47.2M Q3 2025 RYTELO sales

Net loss $18.4M Q3 2025

EPS -$0.03 Q3 2025 basic and diluted loss per share

Cash & securities $421.5M As of Sept 30, 2025

Inventory $95.4M RYTELO supply, Sept 30, 2025

Noncurrent debt $119.3M As of Sept 30, 2025

Stockholders’ equity $248.7M As of Sept 30, 2025

Previous Earnings date Reports

1 past event · Latest: Feb 11 (Neutral)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 11	Earnings date announcement	Neutral	-0.6%	Set date and time for Q4 and full-year 2025 earnings call.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Prior earnings date scheduling news led to a modest -0.62% move, indicating historically muted reactions to timing announcements.

Recent Company History

Recent disclosures show Geron progressing as a commercial-stage hematology company while actively communicating with investors. A prior earnings date announcement on Feb 11, 2026 for Q4 and full-year 2025 results saw only a mild -0.62% move, suggesting that simply setting reporting dates has not been a major price catalyst. Today’s notice for Q1 2026 results and an 8:00 a.m. ET call fits this pattern of routine, calendar-driven updates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

FOSTER CITY, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that it will release its first quarter 2026 financial results and business highlights before the market opens on Wednesday, May 6, 2026 via press release, which will be available on the Investors and Media section of the Company’s website. Geron will host a conference call and webcast at 8:00 a.m. Eastern Time.

A live and archived audio webcast of the conference call will be available from the Investors and Media section of the Company’s website at www.geron.com.

About Geron
Geron is a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer. Our first-in-class telomerase inhibitor RYTELO^® (imetelstat) is approved in the United States and the European Union for the treatment of certain adult patients with lower-risk myelodysplastic syndromes with transfusion dependent anemia. We are also conducting a pivotal Phase 3 clinical trial of imetelstat in JAK-inhibitor relapsed/refractory myelofibrosis, as well as studies in other hematologic malignancies. Inhibiting telomerase activity, which is increased in malignant stem and progenitor cells in the bone marrow, aims to potentially reduce proliferation and induce death of malignant cells. To learn more, visit www.geron.com or follow us on LinkedIn.

Investors and Media
Dawn Schottlandt
Senior Vice President, Investor Relations and Corporate Affairs
dschottlandt@geron.com

FAQ

When will Geron (GERN) announce its Q1 2026 financial results?

Geron will announce Q1 2026 results before the market opens on May 6, 2026. According to the company, the release will include financial results and business highlights and will be posted on the Investors and Media section of its website.

What time is the Geron (GERN) earnings conference call and webcast on May 6, 2026?

The conference call and webcast will begin at 8:00 a.m. Eastern Time on May 6, 2026. According to the company, a live and archived audio webcast will be available from the Investors and Media section of its website.

How can investors access Geron (GERN) May 6, 2026 webcast and archived audio?

Investors can access the live and archived audio webcast via Geron's Investors and Media website at www.geron.com. According to the company, the webcast and archived audio will be available from that site for listening and replay.

Will Geron (GERN) release business highlights alongside Q1 2026 financial results?

Yes. Geron will release business highlights together with its Q1 2026 financial results before market open on May 6, 2026. According to the company, both items will be published in the Investors and Media section of its website.

Is the Geron (GERN) May 6, 2026 event open to the public or investors only?

The conference call and webcast are publicly accessible via the company's investor website. According to the company, both a live audio webcast and an archived replay will be available from the Investors and Media section at www.geron.com.

Where will Geron (GERN) publish the May 6, 2026 press release for Q1 2026 results?

Geron will publish the press release on the Investors and Media section of its website before market open on May 6, 2026. According to the company, the release will contain the quarter's financial results and business highlights.